PWRN1 low expression facilitates cancer progression and is an unfavorable prognosis factor in breast cancer
Abstract Background Triple-negative breast cancer (TNBC) has a poor prognosis due to metastasis and recurrence. The LncRNA PWRN1 is lowly expressed in breast cancer, so we investigated the regulatory mechanism and prognostic value of PWRN1 in TNBC. Methods 135 TNBC patients were included. PWRN1 leve...
Saved in:
| Main Authors: | Hubao Yuan, Yuanwei Liu, Yong Jia, Xiaodong Yang, Dezhen Yang, Ming Dong, Xin Tang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-05-01
|
| Series: | Discover Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s12672-025-02538-8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prognostic significance and therapeutic outcome prediction through serum miR-21 and miR-145 in ovarian cancer
by: SHULIN ZHONG, et al.
Published: (2025-04-01) -
Gene network changes after exposure to nanoliposomes containing antisense miR-21 and miR-373 in bladder cancer Cells: An in vitro model study
by: Omid Nikkhah, et al.
Published: (2025-06-01) -
The expression level of miR-21, a target of the PTEN gene receptor in the PI3K signaling pathway, in clinical samples of triple negative breast cancer
by: Javad Razaviyan, et al.
Published: (2024-04-01) -
Serum levels of miR-21, miR-23a, miR-142-5p, and miR-126 in chronic failure with reduced ejection fraction: a case-control study
by: Lukas Evin, et al.
Published: (2025-05-01) -
MiR‐182‐3p targets TRF2 and impairs tumor growth of triple‐negative breast cancer
by: Roberto Dinami, et al.
Published: (2022-11-01)